<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860658</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.943</article-id><article-id pub-id-type="other">EPV0169</article-id><article-id pub-id-type="pii">S092493382400943X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Vortioxetine as an effective drug in the treatment of depression in adolescents with long QT index. A case report</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Del Sol Calderon</surname><given-names>P.</given-names></name><xref rid="aff2184" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0800" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Izquierdo de la Puente</surname><given-names>A.</given-names></name><xref rid="aff2184" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name><xref rid="aff2185" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a Moreno</surname><given-names>M.</given-names></name><xref rid="aff2184" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff2184"><sup>1</sup>Psychiatry, <institution>Hospital Puerta de Hierro</institution></aff><aff id="aff2185"><sup>2</sup>Psychiatry, <institution>Hospital Universitario Infanta Cristina</institution>, <city>Madrid</city>, <country>Spain</country></aff><author-notes><corresp id="cor0800"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="918">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S454</fpage><lpage>S455</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400943Xa.pdf"/><abstract><sec id="sec4811"><title>Introduction</title><p>This is a 13-year-old female patient admitted to the psychiatric unit active suicidal ideation.</p></sec><sec id="sec4812"><title>Objectives</title><p>the objective is to show through a clinical case how vortioxetine can be safe in adolescents.</p></sec><sec id="sec4813"><title>Methods</title><p>Case report and literature review</p></sec><sec id="sec4814"><title>Results</title><p>She has a history of daily consumption of at least 2 units of cannabis per day. She presents high emotional distress secondary to academic failure, consuming the substance as a coping strategy. Due to prohibition and control by her parents, the patient stopped taking the substance, presenting severe depressive symptoms, self-injury and suicide ideation. For this reason she is admitted to the inpatient psychiatric unit. The electrocardiogram performed on admission shows a corrected QT index of 524. Exploring physical symptoms, she recognized episodes of syncope and palpitations. Coordination was made with cardiology, who performed an echocardiogram with normal results and began follow-up with them without prescribing medication. It was agreed not to use drugs that could prolong the QT index. Evaluating the clinical situation, it was decided to start treatment with Vortioxetine up to 10 mg. With this treatment there was no worsening of the electrocardiogram and the patient&#x02019;s mood improved, anxiety and ideas of death were remitted</p></sec><sec id="sec4815"><title>Conclusions</title><p>This work aims to show how vortioxetine has been effective and safe at the cardiological level in the case of moderate-severe depression in an adolescent with prolonged QT index</p></sec><sec id="sec4816"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>